Extrahepatic Manifestations of Chronic HCV Infection Hepatitis C virus infection is
associated with nonhepatic diseases, including mixed cryoglobulinemic vasculitis, B-cell …

Diabetes mellitus (DM) is common in liver cirrhosis (LC). The pathophysiological association
is bidirectional. DM is a risk factor of LC and LC is a diabetogenic condition. In the recent …

Background and aims Clearance of hepatitis C virus (HCV) is associated with improved
glycometabolic control in patients with diabetes mellitus (DM) but whether this effect is …

The causal link between chronic hepatitis C and glycometabolic alterations has been
confirmed by much biochemical, clinical, and epidemiological research work, but what is still …

Chronic viral hepatitis determines significant morbidity and mortality globally and is caused
by three main etiological actors (Hepatitis B Virus, Hepatitis C Virus, and Hepatitis D Virus) …

Although direct-acting antivirals are very effective and safe drugs, several authors have
reported the alteration of lipid profile during and after anti-HCV therapy suggesting a …

Abstract Background and Aims The beneficial effect of Hepatitis C virus (HCV) eradication
by direct antiviral agents (DAAs) on liver fibrosis is well defined. Despite this, the impact of …

Aim. To assess the effect of treating chronic hepatitis C virus (HCV) infection with direct
acting antiviral drugs (DAAs) on glycemic control in patients with concomitant diabetes …

AIM To analyze the causal correlation between different types of VH and T2D using
Mendelian randomization (MR). METHODS Single nucleotide polymorphisms of VH, chronic …

Recent studies suggested that successful clearance of chronic Hepatitis C Virus (HCV) by
using direct‐acting antiviral (DAA) agents could improve glycemic control in patients with …